Clinical diagnosis of recurrent respiratory papillomatosis with histological confirmation of papilloma.
Cohort 1: Treatment-naïve with respect to Zopa.
Cohort 2: Received a minimum of four administrations of Zopa at 5 × 10\^11 PU per injection and require clinically indicated debulking procedures.
Presence of laryngotracheal papillomas accessible for endoscopic cleanout.
ECOG performance status 0 or 1.
Sexually active participants of reproductive potential must agree to use contraception during treatment and for 120 days for males and 6 months for females after last dose.
Ability to understand and sign informed consent.
You may not be if
Conditions or therapies that increase risk or interfere with participation per investigator judgment.
Systemic corticosteroids \>10 mg prednisone equivalent or other immunosuppressive medications within 14 days prior to dosing.
Other systemic RRP treatments or investigational agents within 30 days.
History of heparin-induced thrombocytopenia or vaccine-induced thrombotic thrombocytopenia.
Active uncontrolled HIV, hepatitis B, or hepatitis C infection.